Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 23 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products include crop protection, animal health, and consumer products. Its crop protection includes Mevalone and Cedroz. Mevalone is a foliar, contact biofungicide which delivers a controlled release pattern of multiple terpene active ingredients. Cedroz is a terpene-based product developed in conjunction with Eastman Chemical Company as a post-planting solution to the problem of root-knot nematodes. The firm's Sustaine encapsulation technology is used to harness the biocidal activity of naturally occurring molecules produced by plants (terpenes) as part of their defence systems. Sustaine is used in a wide range of applications such as agricultural, animal health and consumer products
Follow-Up Questions
Qui est le CEO de Eden Research PLC ?
Mr. Sean Smith est le Chief Executive Officer de Eden Research PLC, il a rejoint l'entreprise depuis 2014.
Quelle est la performance du prix de l'action EDNSF ?
Le prix actuel de EDNSF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Eden Research PLC ?
Eden Research PLC appartient à l'industrie Chemicals et le secteur est Materials
Quelle est la capitalisation boursière de Eden Research PLC ?
La capitalisation boursière actuelle de Eden Research PLC est de $0
Est-ce que Eden Research PLC est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Eden Research PLC, y compris 2 achat fort, 2 achat, 1 maintien, 0 vente et 2 vente forte
